简体中文
  http://www.jcps.ac.cn  
Home   |   About Journal   |   Editorial Board   |   For Authors   |   Subscriptions   |   Contacts Us
Journal of Chinese Pharmaceutical Sciences  2019, Vol. 28 Issue (9): 627-640    DOI: 10.5246/jcps.2019.09.060
Original articles Current Issue | Archive | Adv Search |
Combination therapy of cRGD-DOX self-assembled nanoparticles and bevacizumab for breast cancer
Xueling Wang1, Yanqin Liang1, Yuan Zhang3, Bing He1, Wenbing Dai1, Hua Zhang1, Xueqing Wang1*, Qiang Zhang1,2*
1. Beijing Key Laboratory of Molecular Pharmaceutics and Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China  
2. State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Beijing 100191, China  
3. Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
京ICP备05051953号-6
 Copyright © Journal of Chinese Pharmaceutical Sciences, School of  Pharmaceutical Sciences, Peking University
Tel./Fax: +86-10-82801713, E-mail: jcps@bjmu.edu.cn
Support by
Beijing Magtech Co.ltd , E-mail: support@magtech.com.cn